Pharmacotherapies to enhance smoking cessation during pregnancy

Drug and Alcohol Review

Volumn 22, Issue 2, 2003, Pages 191-202

  Oncken, Cheryl A ^a   Kranzler, H R ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Bupropion; Nicotine replacement; Pregnancy; Smoking

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NICOTINE;

BEHAVIOR THERAPY; CHEWING GUM; DELAYED RELEASE FORMULATION; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; PREGNANCY; REVIEW; SMOKING; SMOKING CESSATION;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR THERAPY; BUPROPION; CHEWING GUM; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; NICOTINE; PREGNANCY; SMOKING; SMOKING CESSATION;

EID: 0037972947     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230100100633     Document Type: Review

References (75)

1. DiFranza JR, Lew RA. Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract 1995;40:385-94.
2. Oncken CA, Hardardottir H, Smeltzer JS. Human studies of nicotine replacement during pregnancy. In: Benowitz NL, ed. Safety and toxicity of nicotine. New York, NY: Oxford University Press, 1998:107-16.
3. Ness RB, Grisso JA, Hirschinger N et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999;340:333-9.
4. Kline J, Levin B, Kinney A, Stein Z, Susser M, Warburton D. Cigarette smoking and spontaneous abortion of known karyotype. Am J Epidemiol 1995;141:417-27.
5. Armstrong BG, McDonald AD, Sloan M. Cigarette, alcohol, and coffee consumption and spontaneous abortion. Am J Public Health 1992;82:85-7.
6. Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993;269:1519-24.
7. Floyd RL, Rimer BK, Giovino GA, Mullen PD, Sullivan SE. A review of smoking in pregnancy: effects on pregnancy outcomes and cessation efforts. Annu Rev Public Health 1993;14:379-411.
8. Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: Examination of the criteria of causation. HumBiol 1994;66:1059-92.
9. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am J Psychiatry 1996;153:1138-42.
10. Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 9-to 12-year olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 1998;20:293-306.
11. Fried PA, Watkinson B, Siegel LS. Reading and language in 9- to 12- year olds prenatally exposed to cigarettes and marijuana. Neurotoxicol Teratol 1997;19:171-83.
12. Cornelius MD, Leech SL, Goldschmidt L, Day NL. Prenatal tobacco exposure: is it a risk factor for early experimentation? Nicotine Tob Res 2000;2:45-52.
13. Kandel DB, Wu P, Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am J Public Health 1994;84:1407-13.
14. Carmichael SL, Ahluwalia IB. Correlates of postpartum relapse. Results from the pregnancy risk assessment monitoring system. Am J Prev Med 2000;19:193-6.
15. Fingerhut LA, Kleinman JC, Kendrick JS. Smoking before, during, and after pregnancy. Am J Public Health 1990;80:541-44.
16. Ventura SJ, Hamilton BE, Matthews TJ, Chandra A. Trends and variations in smoking during pregnancy and low birth weight: Evidence from the birth certificate. Pediatrics. 2003; 111:1176-80.
17. Wakefield M, Gillies P, Graham H, Madeley R, Symonds M. Characteristics associated with smoking cessation during pregnancy among working class women. Addiction 1993;88:1423-30.
18. Windsor RA, Boyd NR, Orleans CT. A meta-evaluation of smoking cessation intervention research among pregnant women: improving the science and art. Health Educ Res 1998;13:419-38.
19. Windsor R, Oncken C, Henningfield J; Hartmann K, Edwards N. Behavioral and pharmacological treatment methods for pregnant smokers: Issues for clinical practice. JAMWA 2000;55:304-10.
20. Fiore MC, Bailey WC, Cohen SJ et al Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service, 2000.
21. Hughes JR, Goldstein MG, Hurt RD, Schiffman S. Recent advances in the pharmacotherapy of smoking cessation JAMA 1999;281:72-6.
22. Gross J, Stitzer ML. Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology 1989;98:334-41.
23. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289-94.
24. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
25. Database and educational resource for the treatment of tobacco dependence: www.treatobacco.net
26. Benowitz NL, Peyton Jacob III, Savanapridi C. Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther 1987;41:467-73.
27. Palmer KJ, Buckley MM, Faulds D. Transdermal nicotine: a review of its pharmacodynamic properties and pharmaco-kinetic properties, and therapeutic efficacy as an aid to smoking cessation. Drugs 1992;44:498-29.
28. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994; 271:1940-7.
29. McNeil. Consumer Products: product information: Nicotrol inhaler. PA: Fort Washington, 1997.
30. Schneider NG, Olmstead R, Nilsson F, Mody FV, Franzon M, Doan K. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction 1996;91:1293-306.
31. Sutherland G, Stapleton JA, Russel MAH et al. Randomised controlled trial of nasal nicotine nasal spray in smoking cessation. Lancet 1992;340:324-9.
32. Gourlay SG, Benowitz NL. Areteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther 1997;62:453-63.
33. Hurt RD, Sachs DP, Glover ED et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337:1195-1202.
34. Shiffman S, Dresler CM, Hajek P, Gilburt SJ, Targett DA, Strahs KR. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002;162:1267-76.
35. Wallstrom M, Nilsson F, Hirsch JM. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 2000;95:1161-71.
36. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301:594-8.
37. Cunningham FG, MacDonald PC, Gant NF et al. The placental hormones. In: Williams Obstetrics, 20th edn. Stamford, CT: Appleton and Lange, 1997:125-50.
38. Allen SS, Hatsukami D, Christianson D, Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine Tobacco Res 2000;2:231-41.
39. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Safety 2001;24:277-322.
40. Longo LD. The biological effects of carbon monoxide on the pregnant woman, fetus, and the newborn infant. Am J Obstet Gynecol 1977; 129:69-103.
41. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta, and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985;8:384-95.
42. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 1998:285;931-45.
43. Slotkin TA, Lappi SE, McCook EC, Lorber BA, Seidler FJ. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. Brain Res Bull 1995;69-75.
44. Werler MM, Pober BR, Holmes LB. Smoking and pregnancy. Teratology 1985;32:473-81.
45. Nafstad P, Kongerud J, Botton G et al. Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Obstet Gynecol Scand 1996;75:902-7.
46. Mulinsky A, Carmella SG, Ye M, Hecht SS. A tobacco-specific carcinogen in the fetus. Prenat Diagn 2000;20:307-10.
47. Wang X, Zuckerman B, Pearson G et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002;287:195-202.
48. Benowitz NL, Dempsey DA, Goldenburg RL et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tobacco Control 2000;9(Suppl III):iii91-4.
49. Gennser G, Marsal K, Brantmark B. Maternal smoking and fetal breathing movements. Am J Obstet Gynecol 1975;123:861-7.
50. Lindblad A, Marsal K. Influence of nicotine chewing gum on fetal blood flow. J Perinat Med 1987;15:13-19.
51. Manning FA, Feyerabend C. Cigarette smoking and fetal breathing movements. Br J Obstet Gynecol 1976;83:262-70.
52. Oncken CA, Hatsukami DK, Lupo VR, Lando HA, Gibeau LM, Hansen RJ. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 1996;59:654-61.
53. Ogburn PL, Hurt RD, Croghan IT et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999;181:736-43.
54. Wisborg K, Henrikson TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study, Obstet Gynecol 2000;96:967-71.
55. Oncken CA, Hardardottir H, Hatsukami DK, Lupo VR, Rodi JF, Smeltzer JS, Effects of transdermal nicotine or smoking on maternal-fetal hemodynamics. Obstet Gynecol 1997;90:569-74.
56. Kapur B, Hackman R, Selby P, Klein J, Koren G. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr Ther Res Clin Exp 2001;62:274-278.
57. Schroeder DR, Ogburn PL, Hurt RD et al. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J Matern Fetal Med 2002;11:100-7.
58. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to maternal and fetal risk. Philadelphia, PA: Lippincott, Williams and Wilkins, 2002.
59. Fiore MC, Bailey WC, Cohen SJ et al. Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service, 2000:92.
60. Oncken CA, Pbert L, Ockene JK, Zapka J, Stoddard A. Nicotine replacement prescription practices of obstetric and pediatrie clinicians. Obstet Gynecol 2000;96:261-5.
61. Mullen PD, Pollack KI, Titus JP, Sockrider MM, Moy JG. Prenatal smoking cessation counseling by Texas obstetricians. Birth 1998;25:25-31.
62. Hickner J, Cousineau A, Messimer S. Smoking cessation during pregnancy: Strategies used by Michigan Family physicians. J Am Board Fam Pract 1990;3:39-42.
63. Windsor RA, Cutter G, Morris J et al. The effectiveness of smoking cessation methods for smokers in public health maternity clinics: a randomized trial. Am J Public Health 1985;75:1389-92.
64. Melvin CL, Dolan-Mullen P, Windsor RA, Whiteside HP, Goldenberg RL. Recommended cessation counseling for pregnant women who smoke: a review of the evidence. Tobacco Control 2000;9(Suppl III):iii80-4.
65. Dolan-Mullen P, Ramirez G, Groff JY. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol 1994;171:1328-34.
66. Macarthur C, Knox EG. Smoking in pregnancy: effects of stopping at different stages. Br J Obstet Gynecol 1988;95:551-5.
67. Ahlstan G, Cnattingius S, Lindmark G. Cessation of smoking during pregnancy improves foetal growth and reduces infant morbidity in the neonatal period. A population-based prospective study. Acta Paediatr 1993;82:177-81.
68. Benowitz NL, Kuyt F, Jacob P III, Jones RT, Osman AL. Cotinine disposition and effects. Clin Pharmacol Ther 1983:309;604-11.
69. Physicians Desk Reference. Montvale NJ: Medical Economics, 2002:1710-15.
70. Daughton DM, Heatley SA, Prendergrast SL. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. Arch Int Med 1991:151:749-52.
71. Institute of Medicine Report. Clearing the smoke (advance copy), New York: National Academy Press, 2001.
72. McBride C, Curry SJ, Lando HA, Pirie PL, Grothaus LL, Nelson JC. Prevention of relapse in women who quit smoking during pregnancy. Am J Publ Health 1999;89:706-11.
73. Luck W, Nau H, Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smoking (letter). N Engl J Med 1984; 311;672.
74. Luck W, Nau H. Nicotine and cotinine concentrations in serum and milk of nursing mothers. Br J Clin Pharmacol 1984;18:9-15.
75. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.